LRRC26
MOLECULAR TARGETleucine rich repeat containing 26
LRRC26 (leucine rich repeat containing 26) is targeted by 12 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting LRRC26
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pterostilbene | 0.69 | 1 |
| 2 | Simvastatin | 0.69 | 1 |
| 3 | Carvedilol | 0.69 | 1 |
| 4 | Disulfiram | 0.69 | 1 |
| 5 | Ethinyl Estradiol | 0.69 | 1 |
| 6 | Ethylestrenol | 0.69 | 1 |
| 7 | Latanoprost | 0.69 | 1 |
| 8 | Nisoldipine | 0.69 | 1 |
| 9 | 3',4'-didemethylnobiletin [Supplementary Concept] | 0.69 | 1 |
| 10 | Ritonavir | 0.69 | 1 |
| 11 | Triamcinolone Acetonide | 0.69 | 1 |
| 12 | Voriconazole | 0.69 | 1 |
About LRRC26 as a Drug Target
LRRC26 (leucine rich repeat containing 26) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 12 compounds with documented LRRC26 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
LRRC26 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.